[ Price : $8.95]
Federal Register Notice: FDA files with the Library of Congress the annual reports of FY 2007 closed-door advisory committee meeti...[ Price : $8.95]
Federal Register Notice: FDAs Drug Safety and Risk Management Advisory Committee will meet 2/1/08 to discuss Luitpold Pharmaceutic...[ Price : $8.95]
The Seattle Times continuing expos of risky, unapproved medical device provokes further FDA action, this time against an illegal H...[ Price : $8.95]
FDA says its safety review of Prilosec and Nexium shows no increased risk of heart problems.[ Price : $8.95]
Consulting editor John Scharmann says recommendations to improve science at FDA depend on raising salary levels equally for field ...[ Price : $8.95]
FDA clears a BMeye 510(k) for the Nexfin hemodynamic monitor.[ Price : $8.95]
FDA issues an approvable letter to GlaxoSmithKline for its restless legs syndrome drug Requip to be used in treating signs and sym...[ Price : $8.95]
Investment advisor Brian Orelli says Johnson & Johnson should advertise its Cypher drug-eluting stent to doctors rather than consu...